C Comera Life Sciences Holdings, Inc.: management transactions · United States · SEC (Form 4) Browse the full directors' dealings record of Comera Life Sciences Holdings, Inc., a listed equity based in United States. Shares are listed on US US, under the supervision of SEC (Form 4). Market capitalisation: €3k. The latest transaction was reported on 28 November 2023 (Acquisition). Among the most active insiders: Cherington Charles. The full history is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 28 November 2023
All Executives31 Thresholds0 Prospectus0 Other0
Declarations 31 total
▲ EVP & CFO · Executives · 27 Nov 2023
10,000 shares @ US$0.0708 1.2% of flow Common Stock SEC:0001062993-23-021522:0
Ideal exit: 23 Aug 2024 (T+270) ● Director · Executives · 15 Nov 2023
3,113 shares 0Common Stock SEC:0001062993-23-021111:0
58,680 shares @ US$0.5112 16.0% of flow Common Stock SEC:0001948079-23-000003:0
Ideal exit: 7 Jun 2024 (T+270) 2,053,789 shares @ US$0.5112 41.8% of flow Common Stock SEC:0001104659-23-099800:0
Ideal exit: 7 Jun 2024 (T+270) 880,195 shares @ US$0.5113 17.5% of flow Common Stock SEC:0001104659-23-095433:0
Ideal exit: 26 Apr 2024 (T+270) ● Director · Executives · 11 Aug 2023
6,636 shares 0Common Stock SEC:0001062993-23-016521:0
▲ Chief Scientific Officer · Executives · 14 Aug 2023
20,000 shares @ US$0.6252 100.0% of flow Common Stock SEC:0001062993-23-016524:0
Ideal exit: 10 May 2024 (T+270) 136,919 shares @ US$0.5112 36.5% of flow Common Stock SEC:0001948079-23-000002:0
Ideal exit: 26 Apr 2024 (T+270) ▲ Director · Executives · 4 Jan 2023
6,756 shares @ US$1.23 50.0% of flow Common Stock SEC:0001062993-23-003497:0
Ideal exit: 1 Oct 2023 (T+270) ▲ Director · Executives · 4 Jan 2023
13,513 shares @ US$1.23 50.0% of flow Common Stock SEC:0001062993-23-003492:0
Ideal exit: 1 Oct 2023 (T+270) ▲ Director · Executives · 4 Jan 2023
33,783 shares @ US$1.23 50.0% of flow Common Stock SEC:0001062993-23-003510:0
Ideal exit: 1 Oct 2023 (T+270) ▲ Director · Executives · 4 Jan 2023
10,979 shares @ US$1.23 50.0% of flow Common Stock SEC:0001062993-23-003495:0
Ideal exit: 1 Oct 2023 (T+270) ▲ Director · Executives · 4 Jan 2023
20,270 shares @ US$1.23 50.0% of flow Common Stock SEC:0001062993-23-003485:0
Ideal exit: 1 Oct 2023 (T+270) ▲ Director · Executives · 4 Jan 2023
81,081 shares @ US$1.23 32.7% of flow Common Stock SEC:0001062993-23-003511:0
Ideal exit: 1 Oct 2023 (T+270) ◆ Director · Executives · 4 Jan 2023
20,270 shares @ US$1.23 50.0% of flow Common Stock SEC:0001062993-23-000612:0
67,567 shares @ US$1.23 45.2% of flow Common Stock SEC:0001948079-23-000001:0
Ideal exit: 1 Oct 2023 (T+270) ◆ Director · Executives · 4 Jan 2023
33,783 shares @ US$1.23 50.0% of flow Common Stock SEC:0001062993-23-000609:0
◆ Director · Executives · 4 Jan 2023
6,756 shares @ US$1.23 50.0% of flow Common Stock SEC:0001062993-23-000611:0
◆ Director · Executives · 4 Jan 2023
13,513 shares @ US$1.23 50.0% of flow Common Stock SEC:0001062993-23-000607:0
743,243 shares @ US$1.23 37.1% of flow Common Stock SEC:0000899243-23-001182:0
Ideal exit: 1 Oct 2023 (T+270) ◆ Director · Executives · 4 Jan 2023
81,081 shares @ US$1.23 32.7% of flow Common Stock SEC:0001062993-23-000610:0
◆ Director · Executives · 4 Jan 2023
10,979 shares @ US$1.23 50.0% of flow Common Stock SEC:0001062993-23-000608:0
3,000 shares @ US$1.3826 2.4% of flow Common Stock SEC:0001948079-22-000002:0
Ideal exit: 5 Aug 2023 (T+270) 3,316 shares @ US$1.5224 0.2% of flow Common Stock SEC:0001062993-22-021051:0
Ideal exit: 17 Jul 2023 (T+270) 4,253 shares @ US$1.6042 0.3% of flow Common Stock SEC:0001062993-22-020905:0
Ideal exit: 11 Jul 2023 (T+270) 25 of 31 declarations
Load more (6 remaining)